Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.

Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2/CD39L1 in hepatocellular carcinoma

Open access
Chiu, David Kung-Chun, Tse, Aki Pui-Wah, Xu, Iris Ming-Jing, Di Cui, Jane, Lai, Robin Kit-Ho, Li, Lynna Lan, Koh, Hui-Yu, Tsang, Felice Ho-Ching, Wei, Larry Lai, Wong, Chun-Ming, Ng, Irene Oi-Lin, Wong, Carmen Chak-Lui · 2017 · Nature Communications

Abstract

Myeloid-derived suppressor cells (MDSCs) possess immunosuppressive activities, which allow cancers to escape immune surveillance and become non-responsive to immune checkpoints blockade. Here we report hypoxia as a cause of MDSC accumulation. Using hepatocellular carcinoma (HCC) as a cancer model, we show that hypoxia, through stabilization of hypoxia-inducible factor-1 (HIF-1), induces ectoenzyme, ectonucleoside triphosphate diphosphohydrolase 2 (ENTPD2/CD39L1), in cancer cells, causing its overexpression in HCC clinical specimens. Overexpression of ENTPD2 is found as a poor prognostic indicator for HCC. Mechanistically, we demonstrate that ENTPD2 converts extracellular ATP to 5′-AMP, which prevents the differentiation of MDSCs and therefore promotes the maintenance of MDSCs. We further find that ENTPD2 inhibition is able to mitigate cancer growth and enhance the efficiency and efficacy of immune checkpoint inhibitors. Our data suggest that ENTPD2 may be a good prognostic marker and therapeutic target for cancer patients, especially those receiving immune therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-017-00530-7

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 ENTPD2 expression in HCC. a Real-time quantitative PCR analysis revealed the expression of ENTPD family members and NT5E in three HCC cell lines, MHCC97L, PLC/PRF/5, and Hep3B, exposed to 20 and 1% O2. Gene expression level was normalized to 20% O2 (n = 3). b TCGA database revealed the expression of ENTPD family members and NT5E in 49 cases of HCC tissues and their corresponding non-tumorous liver (NT) tissues. Gene expression level was normalized to NT. c Waterfall plot showed that ENTPD2 was overexpressed in 58% (36/62) of HCC patients. d Left: ENTPD2 mRNA expression in HCC tissues and their corresponding NT tissues from 62 patients = (Queen Mary Hospital (QMH), the University of Hong Kong (HKU)) was determined by qRT-PCR. Right: ENTPD2 mRNA expression in HCC and NT tissues in 49 HCC patients from the TCGC database. For qRT-PCR, values were normalized with house-keeping gene, HPRT. (Wilcoxon signed-rank test, **P < 0.01, ***P < 0.001) e High expression of ENTPD2 was associated with aggressive clinico-pathological features (n = 62, Student’s t-test). f Data from TCGA showed that high expression (z-score > 1) of ENTPD2 was significantly associated with poorer overall and disease free survival in 368 and 347 HCC patients, respectively (log-rank test, P < 0.01). g Representative IHC staining images of ENTPD2 in human HCC and NT tissues (10 cases). High ENTPD2 staining was only observed in HCC tissues but not in NT tissues
Fig. 1 ENTPD2 expression in HCC. a Real-time quantitative PCR analysis revealed the expression of ENTPD family members and NT5E in three HCC cell lines, MHCC97L, PLC/PRF/5, and Hep3B, exposed to 20 and 1% O2. Gene expression level was normalized to 20% O2 (n = 3). b TCGA database revealed the expression of ENTPD family members and NT5E in 49 cases of HCC tissues and their corresponding non-tumorous liver (NT) tissues. Gene expression level was normalized to NT. c Waterfall plot showed that ENTPD2 was overexpressed in 58% (36/62) of HCC patients. d Left: ENTPD2 mRNA expression in HCC tissues and their corresponding NT tissues from 62 patients = (Queen Mary Hospital (QMH), the University of Hong Kong (HKU)) was determined by qRT-PCR. Right: ENTPD2 mRNA expression in HCC and NT tissues in 49 HCC patients from the TCGC database. For qRT-PCR, values were normalized with house-keeping gene, HPRT. (Wilcoxon signed-rank test, **P < 0.01, ***P < 0.001) e High expression of ENTPD2 was associated with aggressive clinico-pathological features (n = 62, Student’s t-test). f Data from TCGA showed that high expression (z-score > 1) of ENTPD2 was significantly associated with poorer overall and disease free survival in 368 and 347 HCC patients, respectively (log-rank test, P < 0.01). g Representative IHC staining images of ENTPD2 in human HCC and NT tissues (10 cases). High ENTPD2 staining was only observed in HCC tissues but not in NT tissuesCC BY · PubMed Central
Fig. 2 ENTPD2 is a direct transcriptional target of HIF-1α. a Representative IHC staining images of ENTPD2 and two hypoxia markers, CA9 and GLUT1, in human HCC. Overlapping staining pattern of ENTPD2, CA9, and GLUT1 was observed. b ENTPD2 mRNA expression in MHCC97L-EV, -shHIF-1α, and shHIF-2α clones. Cells were exposed to 20 and 1% O2 for 24 h and ENTPD2 mRNA expression was quantitated by qRT-PCR. Values were normalized to 20% O2 EV or WT (n = 3). c ENTPD2 mRNA (left) and protein (right) expression in MHCC97L- HIF-1α-WT (parental) and HIF-1α-knockout (HIF-1α−/−) clones. Cells were exposed to 20 and 1% O2 for 24 h. The mRNA and protein expressions of ENTPD2 were quantitated by qRT-PCR and flow cytometry, respectively. All values were normalized to 20% O2 WT (n = 3). d Three putative hypoxia-responsive elements (HREs), HIF binding consensus sequence, 5′-A/GCGTG-3′ in the promoter region of ENTPD2 were located by in silico analysis. e ChIP assay was performed in MHCC97L cells exposed to 20 and 1% O2 with IgG, HIF-1α, and HIF-1β antibodies. Fold of enrichment was normalized to the according IgG controls (n = 3). Data are presented as mean ± s.d. (Student’s t-test, ***P < 0.001)
Fig. 2 ENTPD2 is a direct transcriptional target of HIF-1α. a Representative IHC staining images of ENTPD2 and two hypoxia markers, CA9 and GLUT1, in human HCC. Overlapping staining pattern of ENTPD2, CA9, and GLUT1 was observed. b ENTPD2 mRNA expression in MHCC97L-EV, -shHIF-1α, and shHIF-2α clones. Cells were exposed to 20 and 1% O2 for 24 h and ENTPD2 mRNA expression was quantitated by qRT-PCR. Values were normalized to 20% O2 EV or WT (n = 3). c ENTPD2 mRNA (left) and protein (right) expression in MHCC97L- HIF-1α-WT (parental) and HIF-1α-knockout (HIF-1α−/−) clones. Cells were exposed to 20 and 1% O2 for 24 h. The mRNA and protein expressions of ENTPD2 were quantitated by qRT-PCR and flow cytometry, respectively. All values were normalized to 20% O2 WT (n = 3). d Three putative hypoxia-responsive elements (HREs), HIF binding consensus sequence, 5′-A/GCGTG-3′ in the promoter region of ENTPD2 were located by in silico analysis. e ChIP assay was performed in MHCC97L cells exposed to 20 and 1% O2 with IgG, HIF-1α, and HIF-1β antibodies. Fold of enrichment was normalized to the according IgG controls (n = 3). Data are presented as mean ± s.d. (Student’s t-test, ***P < 0.001)CC BY · PubMed Central
Fig. 3 ENTPD2 promotes tumor growth and MDSC accumulation. a Proliferation rate of MHCC97L-NTC and -shENTPD2 clones in 20 and 1% O2 (n = 3). BALB/c nude mice were orthotopically implanted with 1 × 106 MHCC97L-NTC, -shENTPD2 clones (n = 5 for each groups). Tumor size was measured with b caliper and c Xenogen imaging. C57BL/6 mice were orthotopically implanted with 3 × 106 Hepa1-6-EV, -shEntpd2_1, and -shEntpd2_2 clones (n = 5 for each group). d Tumor size was measured with caliper. e Tumors collected were dissociated. The percentages of CD11b+Gr1+ cells, CD3+CD4+ cells, and CD3+CD8+ cells in the tumors were determined by flow cytometry (n = 3). f CD11b+Gr1+ cells were isolated from tumor by magnetic cell sorting and co-cultured with CFSE-labeled splenic CD3+CD4+ cells at different T cell : MDSC ratios. The fluorescence intensity of CFSE for each cell would halve after cell division. Cell proliferation of T cells was indicated by reduction of CFSE intensity as a result of cell division. The proliferation index of CD3+CD4+ cells was analyzed by flow cytometry (n = 3). Data are presented as mean ± s.d. (Student’s t-test, *P < 0.05, **P < 0.01, ***P < 0.001)
Fig. 3 ENTPD2 promotes tumor growth and MDSC accumulation. a Proliferation rate of MHCC97L-NTC and -shENTPD2 clones in 20 and 1% O2 (n = 3). BALB/c nude mice were orthotopically implanted with 1 × 106 MHCC97L-NTC, -shENTPD2 clones (n = 5 for each groups). Tumor size was measured with b caliper and c Xenogen imaging. C57BL/6 mice were orthotopically implanted with 3 × 106 Hepa1-6-EV, -shEntpd2_1, and -shEntpd2_2 clones (n = 5 for each group). d Tumor size was measured with caliper. e Tumors collected were dissociated. The percentages of CD11b+Gr1+ cells, CD3+CD4+ cells, and CD3+CD8+ cells in the tumors were determined by flow cytometry (n = 3). f CD11b+Gr1+ cells were isolated from tumor by magnetic cell sorting and co-cultured with CFSE-labeled splenic CD3+CD4+ cells at different T cell : MDSC ratios. The fluorescence intensity of CFSE for each cell would halve after cell division. Cell proliferation of T cells was indicated by reduction of CFSE intensity as a result of cell division. The proliferation index of CD3+CD4+ cells was analyzed by flow cytometry (n = 3). Data are presented as mean ± s.d. (Student’s t-test, *P < 0.05, **P < 0.01, ***P < 0.001)CC BY · PubMed Central
Fig. 4 ENTPD2 hydrolyzes ATP to 5′-AMP that contributes to MDSC maintenance. a The effect of ENTPD2 on MDSC maintenance. Splenic MDSCs isolated from C57BL/6 mice were cultured in conditioned media collected from MHCC97L-EV and -ENTPD2-overexpressing (OE) clones. The percentages of CD11b+Gr1+ cells after 4-day culturing were analyzed (n = 3). b Liquid chromatography-mass spectrometry (LC-MS) analysis of the rate of ATP hydrolysis in conditioned media (n = 3). c Liquid chromatography-mass spectrometry (LC-MS) analysis of adenosine monophosphate (5′-AMP) level in conditioned media. MHCC97L and Hepa1-6 cells were pre-exposed to 20% O2 and 1% O2 for 48 h. Cells were trypsinized and 2 × 106 cells were re-suspended in serum-free DMEM medium supplemented with 100 µM ATP and incubated at 37 °C for 1 h. Conditioned media were collected and subjected to LC-MS analysis (n = 3). d–f The effect of 5′-AMP on MDSC maintenance. Splenic CD11b+Gr1+ cells isolated from C57BL/6 mice were cultured in the presence of d different concentrations of 5′-AMP and e 100 µM 5′-AMP with or without NT5E inhibitor, APCP. The percentages of CD11b+Gr1+ cells after 4-day culturing were analyzed (n = 3). f The effect of 5′-AMP on MDSC induction from bone marrow progenitors. Bone marrow progenitors collected from C57BL/6 mice were cultured with GM-CSF and IL4 with or without 5′-AMP. The percentages of CD11b+Gr1+ cells induced after 4-day culturing were analyzed (n = 3). Data are presented as mean ± s.d. (Student’s t-test, *P < 0.05, **P < 0.01, ***P < 0.001)
Fig. 4 ENTPD2 hydrolyzes ATP to 5′-AMP that contributes to MDSC maintenance. a The effect of ENTPD2 on MDSC maintenance. Splenic MDSCs isolated from C57BL/6 mice were cultured in conditioned media collected from MHCC97L-EV and -ENTPD2-overexpressing (OE) clones. The percentages of CD11b+Gr1+ cells after 4-day culturing were analyzed (n = 3). b Liquid chromatography-mass spectrometry (LC-MS) analysis of the rate of ATP hydrolysis in conditioned media (n = 3). c Liquid chromatography-mass spectrometry (LC-MS) analysis of adenosine monophosphate (5′-AMP) level in conditioned media. MHCC97L and Hepa1-6 cells were pre-exposed to 20% O2 and 1% O2 for 48 h. Cells were trypsinized and 2 × 106 cells were re-suspended in serum-free DMEM medium supplemented with 100 µM ATP and incubated at 37 °C for 1 h. Conditioned media were collected and subjected to LC-MS analysis (n = 3). d–f The effect of 5′-AMP on MDSC maintenance. Splenic CD11b+Gr1+ cells isolated from C57BL/6 mice were cultured in the presence of d different concentrations of 5′-AMP and e 100 µM 5′-AMP with or without NT5E inhibitor, APCP. The percentages of CD11b+Gr1+ cells after 4-day culturing were analyzed (n = 3). f The effect of 5′-AMP on MDSC induction from bone marrow progenitors. Bone marrow progenitors collected from C57BL/6 mice were cultured with GM-CSF and IL4 with or without 5′-AMP. The percentages of CD11b+Gr1+ cells induced after 4-day culturing were analyzed (n = 3). Data are presented as mean ± s.d. (Student’s t-test, *P < 0.05, **P < 0.01, ***P < 0.001)CC BY · PubMed Central
Fig. 5 5′-AMP impairs M-MDSC differentiation to dendritic cells. a The effect of 5′-AMP on apoptotic rate of PMN-MDSCs. Splenic CD11b+Ly6G+ cells isolated from C57BL/6 mice were cultured with or without 100 µM 5′-AMP for annexin V assay at different time points (n = 3). The effect of 5′-AMP or adenosine on M-MDSC differentiation. Splenic CD11b+Ly6C+ cells isolated from C57BL/6 mice were cultured for 4 days b, c with or without 100 µM 5′-AMP, d with 100 µM 5′-AMP in the presence or absence of NT5E inhibitor, APCP, or e with 100 µM 5′-AMP, 100 µM adenosine (ADO), 100 µM 5′-APCP, or 100 µM NECA. Expression for two surface markers, CD11c and F4/80, were analyzed by flow cytometry and the distribution of CD11c−F4/80+ macrophage (Mφ), CD11c+F4/80− and CD11c+F4/80+ dendritic cell (DC) and CD11c−F4/80− M-MDSC populations were determined by the surface markers (n = 3). f The effect of ENTPD2 on the fate of M-MDSCs in vivo. Splenic CD11b+Ly6C+ cells isolated from C57BL/6 mice were stained with fluorescent cell tracking dye CFSE and co-inoculated with Hepa1-6-EV or shEntpd2 clones into C57BL/6 mice subcutaneously (n = 5 for each groups). g The tumors were dissociated and stained with anti-CD11c and anti-F4/80 to examine the differentiation of CFSE-labelled M-MDSCs (n = 5 for each groups). h Tumor weights were measured (n = 5 for each groups). Data are presented as mean ± s.d. (Student’s t-test, *P < 0.05, **P < 0.01, ***P < 0.001)
Fig. 5 5′-AMP impairs M-MDSC differentiation to dendritic cells. a The effect of 5′-AMP on apoptotic rate of PMN-MDSCs. Splenic CD11b+Ly6G+ cells isolated from C57BL/6 mice were cultured with or without 100 µM 5′-AMP for annexin V assay at different time points (n = 3). The effect of 5′-AMP or adenosine on M-MDSC differentiation. Splenic CD11b+Ly6C+ cells isolated from C57BL/6 mice were cultured for 4 days b, c with or without 100 µM 5′-AMP, d with 100 µM 5′-AMP in the presence or absence of NT5E inhibitor, APCP, or e with 100 µM 5′-AMP, 100 µM adenosine (ADO), 100 µM 5′-APCP, or 100 µM NECA. Expression for two surface markers, CD11c and F4/80, were analyzed by flow cytometry and the distribution of CD11c−F4/80+ macrophage (Mφ), CD11c+F4/80− and CD11c+F4/80+ dendritic cell (DC) and CD11c−F4/80− M-MDSC populations were determined by the surface markers (n = 3). f The effect of ENTPD2 on the fate of M-MDSCs in vivo. Splenic CD11b+Ly6C+ cells isolated from C57BL/6 mice were stained with fluorescent cell tracking dye CFSE and co-inoculated with Hepa1-6-EV or shEntpd2 clones into C57BL/6 mice subcutaneously (n = 5 for each groups). g The tumors were dissociated and stained with anti-CD11c and anti-F4/80 to examine the differentiation of CFSE-labelled M-MDSCs (n = 5 for each groups). h Tumor weights were measured (n = 5 for each groups). Data are presented as mean ± s.d. (Student’s t-test, *P < 0.05, **P < 0.01, ***P < 0.001)CC BY · PubMed Central
Fig. 6 Combined treatment with ENTPD2 inhibitor and anti-PD-1/anti-CTLA-4 immune checkpoint inhibitors in C57BL/6 HCC-bearing mice. a C57BL/6 mice were orthotopically implanted with 3 × 106 Hepa1-6. On day 3, mice were administered with vehicle, 3 mg kg−1 ARL67156 or 10 mg kg−1 POM-1 through i.p. injection for 8 consecutive days (n = 5 for each group). Images of tumors collected from mice and tumor size was measured with caliper. b C57BL/6 mice were orthotopically implanted with 3 × 106 Hepa1-6. On day 3, mice were administered with vehicle or 10 mg kg−1 POM-1 i.p. injection for 8 consecutive days, whereas on day 5 and day 9, mice were administered with 4 mg kg−1 control IgG antibody or 2 mg kg−1 anti-PD-1 and anti-CTLA-4 immune checkpoint inhibitors (CTLA-4/PD-1 Ab) through i.p. injection (n = 6 for each group). Images of tumors collected from mice and tumor size was measured with caliper. c Tumors collected at Day 11 were dissociated and the percentages of CD11b+Ly6C+ M-MDSCs and CD11b+Ly6G+ PMN-MDSCs in CD45+ cell population and the total number of MDSCs were determined by flow cytometry. d Tumors collected at Day 18 were sectioned and stained with hematoxylin and eosin for histological analysis (n = 5 for each group). The representative pictures of tumor boundaries (front) and tumor cores (core) of vehicle and combined treatment group were shown. Black arrows indicated the tumor cells. White arrows indicated the immune cells. e Survival test of chemically-induced HCC mice. Two-week-old C57BL/6 mice were administered with single dose of 1 mg kg−1 DEN through i.p. injection (Sigma-Aldrich) and after 8 weeks, with 1.25 ml kg−1 30% CCl4 (Sigma-Aldrich) through i.p. injection twice weekly for 8 weeks. Twenty-six-week-old mice were with administered 10 mg kg−1 POM-1 through i.p. injection thrice weekly or 2 mg kg−1 PD-1and CTLA-4 monoclonal antibodies through i.p. injection twice weekly (n = 5 for each group). Data are presented as mean ± s.d. (Student’s t-test, *P < 0.05, **P < 0.01, ***P < 0.001)
Fig. 6 Combined treatment with ENTPD2 inhibitor and anti-PD-1/anti-CTLA-4 immune checkpoint inhibitors in C57BL/6 HCC-bearing mice. a C57BL/6 mice were orthotopically implanted with 3 × 106 Hepa1-6. On day 3, mice were administered with vehicle, 3 mg kg−1 ARL67156 or 10 mg kg−1 POM-1 through i.p. injection for 8 consecutive days (n = 5 for each group). Images of tumors collected from mice and tumor size was measured with caliper. b C57BL/6 mice were orthotopically implanted with 3 × 106 Hepa1-6. On day 3, mice were administered with vehicle or 10 mg kg−1 POM-1 i.p. injection for 8 consecutive days, whereas on day 5 and day 9, mice were administered with 4 mg kg−1 control IgG antibody or 2 mg kg−1 anti-PD-1 and anti-CTLA-4 immune checkpoint inhibitors (CTLA-4/PD-1 Ab) through i.p. injection (n = 6 for each group). Images of tumors collected from mice and tumor size was measured with caliper. c Tumors collected at Day 11 were dissociated and the percentages of CD11b+Ly6C+ M-MDSCs and CD11b+Ly6G+ PMN-MDSCs in CD45+ cell population and the total number of MDSCs were determined by flow cytometry. d Tumors collected at Day 18 were sectioned and stained with hematoxylin and eosin for histological analysis (n = 5 for each group). The representative pictures of tumor boundaries (front) and tumor cores (core) of vehicle and combined treatment group were shown. Black arrows indicated the tumor cells. White arrows indicated the immune cells. e Survival test of chemically-induced HCC mice. Two-week-old C57BL/6 mice were administered with single dose of 1 mg kg−1 DEN through i.p. injection (Sigma-Aldrich) and after 8 weeks, with 1.25 ml kg−1 30% CCl4 (Sigma-Aldrich) through i.p. injection twice weekly for 8 weeks. Twenty-six-week-old mice were with administered 10 mg kg−1 POM-1 through i.p. injection thrice weekly or 2 mg kg−1 PD-1and CTLA-4 monoclonal antibodies through i.p. injection twice weekly (n = 5 for each group). Data are presented as mean ± s.d. (Student’s t-test, *P < 0.05, **P < 0.01, ***P < 0.001)CC BY · PubMed Central
Fig. 7 Schematic representation of hypoxia-induced MDSC accumulation. Hypoxia stabilizes HIF-1α in cancer cells. HIF-1α binds to the HRE in the promoter of ENTPD2 to initiate transcription in cancer cells. ENTPD2 facilitates the dephosphorylation of extracellular ATP into 5′-AMP. Increase in extracellular 5′-AMP prevents M-MDSCs from maturation at tumor sites, thereby promoting tumor-mediated immune escape. Inhibition of ENTPD2 reduces the number of tumor-infiltrating MDSCs and increase the efficacy of PD-1/CTLA-4 immune checkpoint inhibitors
Fig. 7 Schematic representation of hypoxia-induced MDSC accumulation. Hypoxia stabilizes HIF-1α in cancer cells. HIF-1α binds to the HRE in the promoter of ENTPD2 to initiate transcription in cancer cells. ENTPD2 facilitates the dephosphorylation of extracellular ATP into 5′-AMP. Increase in extracellular 5′-AMP prevents M-MDSCs from maturation at tumor sites, thereby promoting tumor-mediated immune escape. Inhibition of ENTPD2 reduces the number of tumor-infiltrating MDSCs and increase the efficacy of PD-1/CTLA-4 immune checkpoint inhibitorsCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 56 references

Research works printed but not linked: 1

  1. Chiu, D. K. et al. Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) ligand 26. Hepatology 64, 797–813 (2016). · DOI · Paper page

Cited by

See all 469

Metadata

Authors
Chiu, D. K.-C., Tse, A. P.-W., Xu, I. M.-J., Di Cui, J., Lai, R. K.-H., Li, L. L., Koh, H.-Y., Tsang, F. H.-C., Wei, L. L., Wong, C.-M., Ng, I. O.-L., & Wong, C. C.-L.
Affiliations
University of Hong Kong (HK)
Venue
Nature Communications
Published
2017-09-11
Volume
8
Issue
1
Pages
517-517
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2753173755
Cited by
448
References
56
Citations by year
2026: 25 · 2025: 43 · 2024: 57 · 2023: 61 · 2022: 71 · 2021: 76 · 2020: 71 · 2019: 28 · 2018: 16
FWCI
14.23
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • The HKU Scholars Hub (University of Hong Kong) (submittedVersion, cc-by-nc-nd)
Funders
  • University of Hong Kong
  • Health and Medical Research Fund (03142926, T12-704/16-R)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Keywords
myeloid-derived suppressor cells, hepatocellular carcinoma, hypoxia, HIF-1, extracellular ATP, 5'-AMP, tumor immune evasion, immune checkpoint inhibitors, prognostic factors, therapeutic target, MDSC differentiation
MeSH terms
Myeloid-Derived Suppressor Cells, Adenosine Triphosphatases, Hypoxia, Cell Differentiation, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Cell Proliferation, Hypoxia-Inducible Factor 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2/CD39L1 in hepatocellular carcinoma. https://app.cochat.ai/papers/10.1038/s41467-017-00530-7
The paper
Chiu, D. K.-C., Tse, A. P.-W., Xu, I. M.-J., Di Cui, J., Lai, R. K.-H., Li, L. L., Koh, H.-Y., Tsang, F. H.-C., Wei, L. L., Wong, C.-M., Ng, I. O.-L., & Wong, C. C.-L. (2017). Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2/CD39L1 in hepatocellular carcinoma. Nature Communications. https://doi.org/10.1038/s41467-017-00530-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.